#Denmark #Copenhagen #Novartis #Dawn Health #Cora BC

Dawn Health and Novartis Team Up for Cora BC

In a significant development for breast cancer support, Dawn Health has introduced Cora BC, an innovative application designed to assist patients navigating the complexities of breast cancer treatment. The announcement took place in Copenhagen, Denmark, with collaborative efforts from Novartis, aiming to improve the healthcare experience for all breast cancer patients and their families, regardless of where they are in their treatment journey.

Receiving a diagnosis of breast cancer is life-altering, and the ensuing treatment process can be overwhelming. Patients often juggle intricate therapies while grappling with side effects and maintaining communication with healthcare providers. Cora BC seeks to simplify this process by providing users with essential tools for better health management.

A Transformative Tool for Patients

Cora BC empowers patients to track their health effectively, enabling them to visualize their treatment progress through user-friendly graphs. This feature not only offers clarity about treatment trajectories but also helps foster a sense of control that can be crucial for mental well-being. Moreover, the application includes personalized reminders for medication and appointments, promoting adherence to treatment regimens that can span multiple years.

What makes Cora BC particularly remarkable is its ability to tailor content to the unique needs of each patient. This personalization ranges from addressing commonly encountered concerns to offering practical advice, ensuring that patients can access relevant information precisely when they need it most. Beyond mere education, Cora BC supports users in keeping organized with features such as journal entries and consultation preparations, which pave the way for more constructive discussions with healthcare professionals.

Voices from Dawn Health

Highlighting the importance of this tool, Alexander Mandix Hansen, CEO of Dawn Health, emphasized, "Cora BC is more than just an app; it represents a step forward in delivering comprehensive care. By partnering with Novartis, we ensure that patients with breast cancer have access to indispensable resources that make them feel seen, heard, and empowered to achieve optimal outcomes."

With an initial launch in Germany, Cora BC is set to expand to other markets, including the UK, Canada, and Australia. Although it is crucial to note that while this application is a valuable resource, it is not intended to replace medical advice or treatment recommendations. Instead, it aims to streamline the care process and strengthen the relationship between patients and their healthcare providers.

Building on Established Partnerships

This initiative builds on the successful relationship between Dawn Health and Novartis, which previously yielded significant projects like Ekiva MS and Ekiva PNH. Such collaborations underscore the transformative potential of digital health tools in managing chronic conditions. For more information regarding Cora BC, interested parties can visit www.cora-bc.com.

About Dawn Health

Dawn Health stands as a global leader in digital health, specializing in the development of Software as a Medical Device (SaMD) and digital therapies (DTx). By accelerating the market launch of digital solutions, Dawn Health's product platform drives innovation that profoundly impacts individuals living with chronic conditions. Through close partnerships within the life sciences sector, Dawn Health aims to create digital health products that transform patient care with an empathetic, human-centered approach.

For further inquiries, contact Christopher Kold at +45 53 65 31 64 or email Email.